Introduction {#s1}
============

Most eukaryotes harbor microtubule-based cylindrical organelles called centrioles that exhibit a striking ninefold radial symmetry, and which are crucial for a wide range of cellular functions (reviewed in [@bib25]; [@bib2]). In resting cells, centrioles are usually found near the plasma membrane where they organize the formation of flagella and cilia, whereas in proliferating cells centrioles typically reside adjacent to the nucleus, where they recruit pericentriolar material to form the centrosome, the major microtubule organizing center of animal cells. Centrosomes play a major role in directing cellular architecture during interphase and bipolar spindle assembly during mitosis. Centriole numbers are tightly regulated, with centriole duplication occurring only once per cell cycle, in concert with replication of the genetic material (reviewed in [@bib22]). Abnormalities in centriole formation can impair cell signaling and motility owing to defective cilia or flagella, as well as cause spindle positioning defects and genome instability due to aberrations in centrosome numbers and/or sizes. Thus, it is not surprising that centriolar defects are at the root of multiple medical conditions, including primary microcephaly, male sterility and possibly cancer (reviewed in [@bib49]; [@bib3]; [@bib11]; [@bib23]; and [@bib48]).

Five proteins required for centriole assembly were originally identified in *Caenorhabditis elegans* through genetic analysis and functional genomics (reviewed in [@bib25]); these include the recruiting factor SPD-2 ([@bib36]; [@bib54]), the kinase ZYG-1 ([@bib50]), and the coiled-coil domain containing proteins SAS-5, SAS-6 and SAS-4 ([@bib37]; [@bib41]; [@bib15]; [@bib17]; [@bib42]). Following localization of these five proteins to the site of new centriole formation, recruitment of microtubules completes the assembly process, giving rise to a ninefold- symmetric centriole ∼100 nm in diameter ([@bib55]). Functionally equivalent proteins have now been identified throughout eukaryotes ([@bib10]; [@bib31]), indicating an evolutionary shared assembly pathway for centriole formation.

Whereas SAS-6 is critical for establishing the ninefold radial symmetry of centrioles (reviewed in [@bib25]; and [@bib30]), the underlying structural mechanism differs between *C. elegans* and other species. Crystallographic and/or electron microscopic analysis supports the view that recombinant SAS-6 proteins from *Chlamydomonas reinhardtii*, *Danio rerio* and *Leishmania major* form ninefold-symmetric rings ([@bib39]; [@bib72]; [@bib73]). Such SAS-6 rings are thought to dictate the ninefold- symmetrical assembly of the entire centriole. In contrast, similar analysis of *C. elegans* SAS-6 suggests formation of a spiral oligomer with 4.5-fold symmetry per turn, thus generating ninefold symmetry upon two turns of the spiral ([@bib29]).

*C. elegans* SAS-6 physically interacts with SAS-5 ([@bib42]; [@bib60]; [@bib29]; [@bib44]), a protein that shuttles rapidly between the cytoplasm and centrioles throughout the cell cycle ([@bib17]). The presence of SAS-6 and SAS-5 at centrioles is essential for formation of the central tube, a cylindrical structure at the core of the emerging centriole ([@bib55]). Depletion of SAS-5 ([@bib15]; [@bib17]) or SAS-5 mutants that are unable to bind SAS-6 ([@bib17]; [@bib60]; [@bib44]) prevent central tube formation, and therefore centriole assembly. Although SAS-5 has been proposed to assist SAS-6 organization ([@bib60]; [@bib44]), the mechanisms by which this may be achieved are not known, in part because the architecture of SAS-5 has not yet been resolved.

Here, we employ biophysical methods and X-ray crystallography, together with functional assays in *C. elegans* embryos, to demonstrate that large assemblies of SAS-5 are necessary for centriole formation. Our results lead us to propose a working model in which SAS-5 oligomers may assist function by providing a multivalent framework for the assembly of *C. elegans* SAS-6 oligomers.

Results {#s2}
=======

SAS-5 features two independently folded domains {#s2-1}
-----------------------------------------------

Previous attempts at recombinant expression of full-length *C. elegans* SAS-5 (SAS-5~FL~, amino acids 1--404, [Figure 1A](#fig1){ref-type="fig"}) yielded insoluble or marginally soluble material ([@bib60]; [@bib44]). To tackle this problem, we constructed a bacterial expression vector system harboring 13 different solubility-tags, which allowed us to obtain soluble SAS-5~FL~ fused to MsyB ([@bib76]) in quantities sufficient for biophysical analysis ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, which shows all recombinant proteins in this study). Characterization of such purified SAS-5~FL~ using circular dichroism (CD) revealed the presence of protein aggregates ([Figure 1---figure supplement 2A,B](#fig1s2){ref-type="fig"}), a conclusion also supported by size-exclusion chromatography multi-angle light scattering (SEC-MALS, [Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}) and negative-stain electron microscopy ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). We sought to locate the motif in SAS-5 that causes aggregation by expressing a series of MsyB-tagged C-terminal truncation constructs, and observed a significant increase in solubility when comparing a construct encompassing residues 2--279 with one containing residues 2--296 ([Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Secondary structure prediction suggested a β-strand between residues 282 and 295 ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). Excising this region from untagged SAS-5~FL~ (SAS-5~Δ282--295~) or replacing it with a Gly-Ser-Ala-rich flexible linker of equal length (SAS-5~FLEX~) resulted in proteins with CD spectra characteristic of mainly α-helical proteins ([Figure 1B](#fig1){ref-type="fig"}). These results suggest that the predicted β-strand between residues 282--295 of SAS-5 drives formation of large protein aggregates.10.7554/eLife.07410.003Figure 1.SAS-5 comprises two independently folded domains.(**A**) Schematic representation of SAS-5 architecture showing the relative locations and residue boundaries of the coiled-coil and *Implico* domains, the putative SAS-4 binding site ([@bib27]) and the SAS-6 binding site ([@bib60]; [@bib29]). (**B**) Overlaid CD spectra of SAS-5~Δ282--295~ and SAS-5~FLEX~ samples recorded at 10°C, shown as per residue molar elipticity vs wavelength. The semi-quantitative contribution of secondary structure elements in each spectrum is deconvoluted in the bar charts on the left. Grey color corresponds to random coil, green to β-strand and red to α-helical segments. (**C**) Thermal unfolding profiles of the same samples monitored by recording molar elipticity at 222 nm as a function of temperature, and graphical representation of the melting transition temperatures observed in each sample. (**D**--**G**) Similar CD spectra and thermal unfolding profiles of (**D**,**E**) SAS-5~CC~ and SAS-5~Imp~, and (**F**,**G**) SAS-5~125--265~ samples.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.003](10.7554/eLife.07410.003)10.7554/eLife.07410.004Figure 1---figure supplement 1.Recombinant proteins sample quality.(**A**,**B**) Sections of SDS-PAGE showing Coomassie-stained samples of recombinant proteins used in this study. Panel **A** groups proteins with molecular weight over 30 kDa; panel **B** shows smaller proteins. Individual gel sections have been compressed or expanded along the vertical axis to match the molecular weight marker, and their contrast levels have been equalized.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.004](10.7554/eLife.07410.004)10.7554/eLife.07410.005Figure 1---figure supplement 2.SAS-5 forms protein aggregates in vitro.(**A**) CD spectrum of SAS-5~FL~ at 10°C shown as per residue molar elipticity against wavelength, and (**B**) thermal unfolding profile of the same protein monitored by recording molar elipticity at 222 nm as a function of temperature. The CD spectrum is highly similar to that of protein aggregates characterized elsewhere ([@bib18]). (**C**) Overlay of SEC-MALS chromatograms of SAS-5~FL~ samples at multiple concentrations, showing scaled light scattering intensity vs elution volume. (**D**) Representative negative stain electron micrograph of SAS-5~FL~ and high-magnification view of the boxed section.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.005](10.7554/eLife.07410.005)10.7554/eLife.07410.006Figure 1---figure supplement 3.A short SAS-5 segment promotes protein aggregation.(**A**, **B**) Coomassie-stained SDS-PAGE of metal-affinity purified SAS-5 variants, corresponding to MsyB-tagged full-length protein and C-terminal truncations (**A**). The expected SAS-5-MsyB protein bands are indicated by black arrows. Soluble protein yields increased significantly upon truncation of residues 280--296 (compare lanes 3 and 4). Excision of this protein segment (SAS-5~Δ282--295~-MsyB) or substitution by a flexible linker (SAS-5~FLEX~-MsyB) improved soluble yields of the full-length protein (**B**, compare to right-most lane of panel **A**).**DOI:** [http://dx.doi.org/10.7554/eLife.07410.006](10.7554/eLife.07410.006)10.7554/eLife.07410.007Figure 1---figure supplement 4.SAS-5 secondary structure and disorder predictions.(**A**) Schematic representation and relative locations of secondary structure elements predicted from the SAS-5 amino acid sequence by PSIPRED ([@bib33]). (**B**) Disorder probability per amino acid residue predicted from the SAS-5 sequence by DISOPRED3 ([@bib32]).**DOI:** [http://dx.doi.org/10.7554/eLife.07410.007](10.7554/eLife.07410.007)10.7554/eLife.07410.008Figure 1---figure supplement 5.The SAS-5 N- and C-terminal segments are unstructured in isolation.(**A**) Overlaid CD spectra of SAS-5 N-terminal (residues 2--122) and C-terminal (residues 269--404) fragments recorded at 10°C. The semi-quantitative contribution of secondary structure elements in each spectrum is deconvoluted in the bar chart left. Grey colour corresponds to random coil, green to β-strand and red to α-helical segments. (**B**) Thermal unfolding profiles of the same samples based on their CD signal at 222 nm.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.008](10.7554/eLife.07410.008)

Interestingly, thermal unfolding of the soluble SAS-5~Δ282--295~ and SAS-5~FLEX~ variants showed a two-step cooperative melting process, thus revealing the presence of two independently folded domains ([Figure 1C](#fig1){ref-type="fig"}). Sequence-based prediction suggested the presence of a coiled coil spanning residues 125--180, as well as of three tightly-spaced α-helices (residues 210--265); these two elements are separated from each other by a presumed disordered linker of ∼30 residues ([Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}). We expressed both the coiled coil (SAS-5~CC~) and the predicted helical region (SAS-5~Imp~ for *Implico*, see below) and performed CD analysis. SAS-5~CC~ displayed a double-minimum spectrum ([Figure 1D](#fig1){ref-type="fig"}) characteristic of α-helical coiled coils, and exhibited moderate thermal stability in isolation (apparent melting transition temperature, T~m~ ∼ 37°C, [Figure 1E](#fig1){ref-type="fig"}). In contrast, CD of SAS-5~Imp~ revealed a very stable (T~m~ ∼ 72°C) α-helical domain ([Figure 1D,E](#fig1){ref-type="fig"}). A SAS-5 construct that combined both the coiled coil and the α-helical domain (SAS-5~125--265~, residues 125--265) showed CD spectra and a two-step thermal unfolding profile highly similar to that of SAS-5~Δ282--295~ and SAS-5~FLEX~ (compare [Figure 1F,G](#fig1){ref-type="fig"} with [Figure 1B,C](#fig1){ref-type="fig"}). We attribute the first melting transition of SAS-5~125--265~ (T~m~ of ∼50°C) to unfolding of the coiled-coil domain and the second (T~m~ of ∼70°C) to unfolding of the *Implico* domain. Moreover, CD spectra of isolated SAS-5 N-terminal (residues 2--122) or C-terminal (269--404) fragments showed no persistent secondary structure or cooperative thermal unfolding ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}), consistent with similar previous analysis of the SAS-5 N-terminus ([@bib65]). Overall, these findings led us to conclude that the segment between residues 125--265 contains two independently folded domains and encompasses all structured elements of SAS-5.

The SAS-5 coiled coil forms a moderately stable trimer {#s2-2}
------------------------------------------------------

We next set out to determine the X-ray crystallographic structures of the two independently folded domains. Native crystals of SAS-5~CC~ diffracted to 1.8 Å resolution, whilst phases for structure solution were determined by single anomalous dispersion (SAD) using trimethyl lead acetate derivatized crystals ([Tables 1, 2](#tbl1 tbl2){ref-type="table"}). The structure of SAS-5~CC~ suggested a parallel trimeric coiled coil, although this arrangement is distorted by crystal packing that intercalates the ends of successive triple helical bundles ([Figure 2A](#fig2){ref-type="fig"}). To correct for these distortions, we performed molecular dynamics (MD) simulations starting from the crystallographic structure of SAS-5~CC~, which rapidly converged to a trimeric coiled-coil structure ([Figure 2B--D](#fig2){ref-type="fig"}). SEC-MALS analysis of a slightly longer coiled-coil construct (SAS-5~CC-L~, residues 101--206) demonstrated formation of a trimer in solution in a concentration-dependent manner, with apparent K~d~ of ∼3 μM ([Figure 2G,H](#fig2){ref-type="fig"}). Both the crystallographic model and MD simulations show a series of hydrophobic residues (W133, M137, L141, I144, I148, L159, M167 and M171) forming the core of the coiled coil and enabling trimer formation ([Figure 2E,F](#fig2){ref-type="fig"}). Interestingly, we found that all these residues are conserved or conservatively substituted in SAS-5 homologs in other *Caenorhabditis* species, suggesting functional relevance ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). To investigate the stability of the coiled-coil domain across nematode evolution, we expressed constructs corresponding to SAS-5~CC-L~ from *Caenorhabditis brenneri*, *Caenorhabditis briggsae*, *Caenorhabditis remanei*,*Caenorhabditis* *sinica* and *Caenorhabditis* *tropicalis*. In all cases, SEC-MALS analysis showed similar oligomerization properties and apparent affinities as for *C. elegans* SAS-5~CC-L~ ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). Taken together, these data suggest that the trimeric coiled coil is an evolutionary conserved feature of nematode SAS-5 proteins.10.7554/eLife.07410.009Table 1.Crystallographic data collection and refinement statistics**DOI:** [http://dx.doi.org/10.7554/eLife.07410.009](10.7554/eLife.07410.009)Protein*SAS-5*~*CC*~*SAS-5*~*CC*~ (Pb-derivative)*SAS-5*~*Imp*~*SAS-5*~*Imp*~ (Hg-derivative)PDB code4YV4--4YNH--Space groupP 2~1~ 2~1~ 2~1~P 2~1~ 2~1~ 2~1~P 1 2~1~ 1P 1 2~1~ 1Unit cell (Å, °)a = 46.52;a = 46.32;a = 27.18;a = 27.85;b = 55.10;b = 52.99;b = 36.29;b = 36.65;c = 191.50c = 191.55c = 42.60;c = 42.13;β = 97.50β = 97.74BeamlineDLS/I04DLS/I03ESRF ID14-4DLS/I02Wavelength (Å)0.97950.9470.9001.007Resolution range (Å)41.90-1.8041.70-1.9018.49-1.0041.75-1.70High resolution shell (Å)1.84-1.80[\*](#tblfn1){ref-type="table-fn"}1.95-1.90[†](#tblfn2){ref-type="table-fn"}1.05-1.001.74-1.70R~merge~[‡](#tblfn3){ref-type="table-fn"}0.047 (1.092)0.089 (1.088)0.108 (0.763)0.065 (0.541)R~pim~[‡](#tblfn3){ref-type="table-fn"}0.034 (0.988)0.014 (0.680)0.044 (0.314)0.017 (0.151)Completeness[‡](#tblfn3){ref-type="table-fn"} (%)98.1 (97.8)80.1 (33.6)[§](#tblfn4){ref-type="table-fn"}99.4 (98.3)85.6 (39.4)[\#](#tblfn5){ref-type="table-fn"}Multiplicity[‡](#tblfn3){ref-type="table-fn"}2.9 (2.9)9.3 (3.6)6.9 (6.8)18.4 (13.6)Mean I/σ(I)[‡](#tblfn3){ref-type="table-fn"}7.4 (0.7)13 (0.9)12.0 (4.2)26.5 (4.5)Phasing No. of heavy atom sites--9--2 Resolution--41.70-1.90--41.75-1.70 FOM *initial*[¶](#tblfn6){ref-type="table-fn"}--0.39--0.39 FOM *DM*[\*\*](#tblfn7){ref-type="table-fn"}--0.61--0.75Refinement statistics *R*~work~ (reflections)20.9% (30,118)--12.8% (42,016)-- *R*~*f*ree~(reflections)23.8% (1600)--14.9% (2232)--Number of atoms Protein atoms3647--2040 (including H)-- Ligands25------ Water261--124--Average B factors (Å^2^) Protein atoms50.9--10.9-- Water46.5--23.5--RMSD from ideal values Bonds / angles (Å/°)0.01 / 0.95--0.007 / 1.152--MolProbity statistics[††](#tblfn8){ref-type="table-fn"} Ramachandran favored (%)99.5%--99.2%-- Ramachandran disallowed (%)0%--0%-- Clashscore (percentile)2.49 (99^th^)--0.98 (98^th^)-- MolProbity score (percentile)1.11 (100^th^)--0.79 (99^th^)--[^1][^2][^3][^4][^5][^6][^7][^8]10.7554/eLife.07410.010Table 2.Anisotropy correction statistics[\*](#tblfn9){ref-type="table-fn"} for native SAS-5~CC~ crystallographic data**DOI:** [http://dx.doi.org/10.7554/eLife.07410.010](10.7554/eLife.07410.010)Resolution (Å)Number of observed reflectionsRedundancyCompleteness (%)R~merge~ (%)Mean I/σ(I)BeforeAfterBeforeAfterBeforeAfterBeforeAfterBeforeAfter8.05142814282.32.392.392.32.92.922.321.95.69261725982.52.592.192.23.33.322.321.94.65332233172.62.694.494.44.04.022.4224.03394939232.62.693.393.23.63.622.722.33.6458145272.72.795.895.83.73.821.721.33.29492549572.62.695.195.34.14.119.819.43.04576057032.82.896.996.75.05.017.116.82.85602660032.82.896.396.45.15.114.213.92.68669666492.92.997.897.86.56.412.111.92.55709870982.9398.698.57.57.510.19.92.43717871362.82.898.298.19.49.38.28.12.32782477813398.999.111.811.76.86.72.23784472332.82.697.491.115.914.95.25.42.158551660932.399.079.620.415.94.45.32.08875757263299.066.929.320.03.14.42.01870745422.91.598.751.841.822.92.34.11.959329335531.199.133.959.124.01.74.21.9915023412.90.798.120.593.330.21.13.81.859824153230.599.211.6114.028.60.94.51.897485022.80.197.93.9143.131.80.83.9total13331492,9602.9297.668.24.94.48.211.3[^9]10.7554/eLife.07410.011Figure 2.The SAS-5 coiled coil forms a parallel trimer.(**A**) Schematic representation of the SAS-5~CC~ crystallographic structure in purple. The protein N- and C-termini are indicated, as is the area where successive molecules intercalate in the crystal, leading to distortions of the coiled-coil structure; an intercalating molecule is shown here in white. (**B**,**C**) Average distance between the centers of the three α-helices at the N-terminus (**B**) or the C-terminus (**C**) of the coiled coil as a function of time in MD simulations. The distances at the initially frayed ends of the coiled coil decreased rapidly from ∼16 nm to ∼11 nm as the structure converged to a canonical trimeric arrangement. (**D**) Schematic representation of the coiled-coil structure at the start (left, purple) and the end (right, grey) of MD simulations. The helix centers whose distances are plotted in panels **B** and **C** are shown as blue and red spheres, respectively. (**E**,**F**) Magnified view of the coiled-coil hydrophobic core from the crystallographic structure. Residues at the C-terminus (**E**) and N-terminus (**F**) of the coiled coil are shown as sticks; charged substitutions at L141 and M167 disrupted coiled-coil oligomerization. (**G**) Overlay of SEC-MALS chromatograms of SAS-5~CC-L~ at multiple concentrations, showing scaled light scattering intensity vs elution volume. The calculated molecular weight for each trace is shown as continuous line over the chromatogram peak, and corresponds to the right--hand axis. Chromatograms of samples at the highest two concentrations show evidence of protein overloading on the size-exclusion column. (**H**) Plot of average molecular weight from SEC-MALS analysis as a function of on-column protein concentration. The apparent K~d~, and molecular sizes of monomers, dimers and trimers are indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.011](10.7554/eLife.07410.011)10.7554/eLife.07410.012Figure 2---figure supplement 1.Alignment of SAS-5 coiled coils from the *Caenorhabditis* genus.Alignment of nematode SAS-5 coiled-coil sequences from the *Caenorhabditis* genus by MergeAlign ([@bib14]) and plotted by ESPript ([@bib61]). The protein secondary structure inferred from the crystallographic structure of SAS-5~CC~ is shown schematically on top. Universally conserved residues are highlighted in red; conservatively substituted residues are shown in red.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.012](10.7554/eLife.07410.012)10.7554/eLife.07410.013Figure 2---figure supplement 2.The trimeric SAS-5 coiled coil is an evolutionary conserved feature.(**A**) Overlay of SEC-MALS chromatograms of a *C. briggsae* SAS-5 construct spanning residues 96--199, equivalent to *C. elegans* SAS-5~CC-L~, in multiple concentrations, and (**B**) plot of average molecular weight calculated from SEC-MALS analysis as a function of on-column protein concentration. The apparent K~d~ and molecular sizes of monomers, dimers and trimers are indicated. Chromatograms of samples at the highest protein concentration show evidence of overloading the size exclusion column. (**C**--**J**) Similar chromatograms and plots of *C. brenneri* SAS-5 residues 1--82 (**C**, **D**), *C. remanei* SAS-5 residues 98--206 (**E**, **F**), *C. sinica* SAS-5 residues 94--204 (**G**, **H**) and *C. tropicalis* SAS-5 residues 94--199 (**I**, **J**).**DOI:** [http://dx.doi.org/10.7554/eLife.07410.013](10.7554/eLife.07410.013)

SAS-5~Imp~ is a structurally novel dimeric domain {#s2-3}
-------------------------------------------------

We next turned our attention to the second independently folded domain, SAS-5~Imp~. We found that this newly recognized domain is highly conserved amongst *Caenorhabditis* species ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Importantly, SEC-MALS experiments revealed that SAS-5~Imp~ forms a stable dimer ([Figure 3A](#fig3){ref-type="fig"}). Crystals of SAS-5~Imp~ diffracted to 1.0 Å resolution and experimental phases were determined by SAD from mercury acetate derivatized samples ([Table 1](#tbl1){ref-type="table"}). The SAS-5~Imp~ structure revealed a dimer composed of interlocked chains arranged in an antiparallel fashion ([Figure 3B](#fig3){ref-type="fig"}). Each chain features three α-helices (A1 to A3 and B1 to B3) that interact in a pairwise manner (A1--B3, A2--B2 and A3--B1). Proline residues at the linkers between helices allow for tight 90° turns ([Figure 3C](#fig3){ref-type="fig"}), resulting in a very compact dimer of just ∼4 nm in diameter. The dimer interface ([Figure 3D](#fig3){ref-type="fig"}) involves the majority of hydrophobic core residues (I219, I225, A229, L230, I232, I233, L237, F243, I247, V250, L251); thus, breaking the dimer is expected to unfold the SAS-5~Imp~ domain. Given the high thermal stability of SAS-5~Imp~ ([Figure 1E](#fig1){ref-type="fig"}), this suggests formation of stable dimers even at very low protein concentrations. This interlocked tight dimer is a novel structural feature that we named *Implico*, from Latin *to entangle*.10.7554/eLife.07410.014Figure 3.The SAS-5 Implico domain comprises a novel type of protein dimer.(**A**) Overlay of SEC-MALS chromatograms of SAS-5~Imp~ in multiple concentrations showing formation of a stable dimer. (**B**) Two orthogonal views of the SAS-5~Imp~ crystallographic structure in schematic representation. The α-helices are denoted A1--A3 and B1--B3 for the two protein chains (red and grey, respectively). The N- and C-termini are indicated. (**C**) Magnified view of a single SAS-5~Imp~ protein chain in schematic representation, showing the proline residues (space-filling representation) at the tight turns between α-helices. (**D**) Two views of the SAS-5~Imp~ dimeric interface, with one chain represented as surface and the other as ribbon. Hydrophobic residues at the dimer interface are shown as sticks on the ribbon chain, and their location is indicated on the surface. Surface colors are a gradient from blue to orange representing residue hydrophobicity in the Kyte-Doolittle scale ([@bib40]). Blue corresponds to −4.5 in this scale (most hydrophilic), white to 0 and orange to 4.5 (most hydrophobic).**DOI:** [http://dx.doi.org/10.7554/eLife.07410.014](10.7554/eLife.07410.014)10.7554/eLife.07410.015Figure 3---figure supplement 1.Alignment of SAS-5 Implico domains from the *Caenorhabditis* genus.Alignment of nematode SAS-5 *Implico* domain sequences from the *Caenorhabditis* genus by MergeAlign ([@bib14]). The protein secondary structure inferred from the crystallographic structure of SAS-5~Imp~ is shown schematically on top. Universally conserved residues are indicated by red highlight; conservatively substituted residues are shown in red.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.015](10.7554/eLife.07410.015)

The molecular architecture of SAS-5 drives the formation of higher-order assemblies {#s2-4}
-----------------------------------------------------------------------------------

Together, the two oligomerization domains of SAS-5 have the potential to drive formation of protein assemblies of higher-order than merely dimers or trimers. We envision that SAS-5 would readily dimerize even at low concentrations via the *Implico* domain, as oligomerization of this domain is tighter compared to that of the SAS-5 coiled coil. Such SAS-5 dimers could then come together to form higher-order configurations. To test this possibility, we performed SEC-MALS experiments on MsyB-tagged SAS-5~FLEX~, which revealed concentration-dependent oligomerization of SAS-5 from dimers to an approximately equimolar population of tetramers and hexamers ([Figure 4A,B](#fig4){ref-type="fig"}). Analogous results were obtained with a MsyB-tagged SAS-5 construct that lacks the disordered protein C-terminus (SAS-5~2--265~) ([Figure 4C,D](#fig4){ref-type="fig"}). Moreover, native mass-spectrometry of SAS-5~2--265~ also supported the presence of higher-order protein assemblies up to hexamers in solution ([Figure 4E](#fig4){ref-type="fig"}). Taken together, these data support the notion that the SAS-5 coiled coil promotes the association of protein dimers towards higher-order assemblies. Furthermore, our results are consistent with an earlier SEC-MALS analysis of MBP-tagged SAS-5 constructs of residues 1--260, which showed formation of tetramers at an unspecified protein concentration ([@bib65]).10.7554/eLife.07410.016Figure 4.SAS-5 forms higher-order assemblies in solution.(**A**) Overlay of SEC-MALS chromatograms of MsyB-tagged SAS-5~FLEX~ in multiple concentrations and (**B**) plot of average molecular weight from SEC-MALS analysis as a function of on-column protein concentration. The apparent K~d~ and molecular sizes of dimers, tetramers and hexamers are indicated. SAS-5~FLEX~-MsyB reaches an equimolar hexamer to tetramer ratio at the highest concentration we could assess. Fitting the experimental data under the assumption of ultimate hexamer formation yielded K~d~ values comparable to those of the SAS-5 coiled coil in isolation (compared B with [Figure 2H](#fig2){ref-type="fig"}). (**C**,**D**) Similar SEC-MALS analysis of MsyB-tagged SAS-5~2--265~. SAS-5~2--265~-MsyB reaches a 3:1 hexamer to tetramer ratio at the highest concentration point. (**E**) Native mass-spectrometry electrospray ionization spectrum of a 20 μM sample of SAS-5~2--265~, showing relative abundance of protein species as a function of mass to charge ratio. The charged states and protein oligomeric forms corresponding to specific peaks are indicated. Odd-numbered oligomeric forms (monomers, trimers etc) likely correspond to in-flight breakdown of higher- order protein assemblies.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.016](10.7554/eLife.07410.016)

To further probe the architectural model of higher-order SAS-5 assemblies, we proceeded to disrupt each oligomerization interface by engineering charged residues in place of core hydrophobic amino acids. The CD spectra of the resulting SAS-5~CC~ L141E mutant showed significant reduction of α-helical content in the coiled coil and a striking reduction in stability (T~m~ \< 10°C, [Figure 5---figure supplement 1A,B](#fig5s1){ref-type="fig"}), whereas that of the SAS-5~Imp~ I247E mutant showed absence of α-helical structure and complete loss of cooperativity upon thermal unfolding ([Figure 5---figure supplement 1C,D](#fig5s1){ref-type="fig"}).

We next engineered the same substitutions in the SAS-5~2--265~ construct to selectively disrupt each oligomerization interface whilst leaving the other intact. We found that the thermal unfolding profile of a SAS-5~2--265~ L141E mutant showed a reduction in stability of the coiled coil by approximately 25°C, whereas stability of the *Implico* domain was not affected ([Figure 5A,B](#fig5){ref-type="fig"}). Substituting an additional core hydrophobic residue of the coiled coil (SAS-5~2--265~ L141E/M167E) effectively abrogated coiled coil formation, again with no effect on the *Implico* domain ([Figure 5A,B](#fig5){ref-type="fig"}). As anticipated, coiled coil disruptions in either SAS-5~2--265~ L141E or L141E/M167E mutants yielded a stable dimer in SEC-MALS experiments ([Figure 5C,D](#fig5){ref-type="fig"}), mediated by the *Implico* domain. Furthermore, we found that a SAS-5~2--265~ I247E mutant, where the *Implico* domain is disrupted, displayed a single-step thermal unfolding profile as measured by CD with a T~m~ similar to that of the SAS-5 coiled coil in isolation (compare [Figure 5A,B](#fig5){ref-type="fig"} to [Figure 1E](#fig1){ref-type="fig"}). SEC-MALS analysis of the same construct shows a concentration-dependent trimerization, again consistent with formation of just the SAS-5 coiled coil ([Figure 5E,F](#fig5){ref-type="fig"}). Finally, a SAS-5 mutant where both oligomerization interfaces are disrupted, SAS-5~2--265~ L141E/I247E, showed no cooperativity upon thermal unfolding ([Figure 5A,B](#fig5){ref-type="fig"}) and remained monomeric in solution ([Figure 5G](#fig5){ref-type="fig"}). Together, our results support the notion that the two SAS-5 oligomerization domains self-associate independently from one another, and that together they allow formation of higher-order SAS-5 assemblies.10.7554/eLife.07410.017Figure 5.Sequential disruption of SAS-5 oligomeric interfaces.(**A**) Thermal unfolding profiles monitored by CD of SAS-5~2--265~ wild-type and mutants that disrupt the coiled coil (L141E, L141E/M167E) or the *Implico* (I247E) oligomerization interface. (**B**) Graphical representation of the melting transition temperatures observed in each SAS-5~2--265~ variant. (**C**,**D**) Overlay of SEC-MALS chromatograms of SAS-5~2--265~ L141E (**C**) or L141E/M167E (**D**) variants in multiple concentrations. (**E**) Similar SEC-MALS analysis of SAS-5~2--265~ I247E and (**F**) plot of average molecular weight from SEC-MALS analysis of this variant as a function of on-column protein concentration. The apparent K~d~ and molecular sizes of monomers, dimers and trimers are indicated. (**G**,**H**) Overlay of SEC-MALS chromatograms from the SAS-5~2--265~ L141E/I247E variant (**G**), and the MsyB-tagged SAS-5~2--265~ wild-type as reference (**H**).**DOI:** [http://dx.doi.org/10.7554/eLife.07410.017](10.7554/eLife.07410.017)10.7554/eLife.07410.018Figure 5---figure supplement 1.Single amino acid mutations disrupt the SAS-5~CC~ and SAS-5~Imp~ domains.(**A**) Overlaid CD spectra of SAS-5~CC~ wild-type and L141E mutant samples recorded at 10°C. The semi-quantitative contribution of secondary structure elements in each spectrum is deconvoluted in the bar charts on the left. Grey color corresponds to random coil, green to β-strand and red to α-helical segments. (**B**) Thermal unfolding profiles of the same samples from their CD signal at 222 nm, and graphical representation of the melting transition temperatures observed in each sample. (**C**, **D**) Similar CD spectra and thermal unfolding profiles of SAS-5~Imp~ wild-type and I247E mutant samples.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.018](10.7554/eLife.07410.018)

Higher-order assemblies of SAS-5 are required for centriole duplication in vivo {#s2-5}
-------------------------------------------------------------------------------

We next sought to assess the role of higher-order SAS-5 assemblies in vivo. To this end, we generated *C. elegans* transgenic animals expressing either GFP-SAS-5 (wild-type), or GFP-SAS-5 L141E or GFP-SAS-5 I247E mutant versions. All exons of the *sas-5* sequence were recoded in the transgenic constructs to confer resistance to RNAi directed against endogenous *sas-5*. Worms were subjected to *sas-5* RNAi and the resulting embryos analyzed by time-lapse differential interference contrast (DIC) microscopy as a means to assay centriole formation. In wild-type embryos ([Figure 6A](#fig6){ref-type="fig"} and [Video 1](#video1){ref-type="other"}), the sperm contributes the sole pair of centrioles to the newly fertilized embryo. Following the first round of centriole duplication in the zygote, the two centrosomes, now each with a pair of centrioles, direct assembly of a bipolar spindle during the first mitotic division. At the two-cell stage, centrioles separate and duplicate, leading to bipolar spindle assembly in each blastomere and resulting in a signature 4-cell stage configuration following mitotic exit ([Figure 6A](#fig6){ref-type="fig"} and [Video 1](#video1){ref-type="other"}). In *sas-5*(*RNAi*) embryos, the sperm, which is not affected by RNAi under these experimental conditions, contributes two normal centrioles to the zygote; these paternally contributed centrioles each recruit pericentriolar material and direct bipolar spindle assembly during the first mitotic division ([@bib17]). However, due to depletion of the maternal pool of SAS-5, centriole duplication does not occur, leading to monopolar spindle assembly in each blastomere at the second cell cycle ([Figure 6B](#fig6){ref-type="fig"}, [Video 2](#video2){ref-type="other"}). As a result, a four-cell configuration is never observed in *sas-5*(*RNAi*) embryos ([Figure 6B](#fig6){ref-type="fig"}).10.7554/eLife.07410.019Figure 6.Both SAS-5 oligomerization interfaces are essential for centriole duplication in *C. elegans* embryos.Wild type (**A**,**B**), *gfp::sas-5* (**C**), *gfp::sas-5\[L141E\]* (**D**), and *gfp::sas-5\[I247E\]* (**E**) adult worms were subjected to *sas-5*(*RNAi*) or left untreated (**A**). The resulting embryos were imaged by time-lapse DIC microscopy (**A**--**E**, see corresponding [Videos 1--5](#video1 video2 video3 video4 video5){ref-type="other"}) or fixed and analyzed by immunofluorescence (**F**--**H**). (**A**--**E**) Embryos at the onset of cleavage furrow ingression (top) and at the end of the second cell cycle (bottom); time stamp in mm:ss from the beginning of cleavage furrow ingression at the first mitosis. The percentage of embryos that reach the four-cell stage is shown below each image, along with the number of embryos (n) analyzed per condition. (**F**--**H**) Embryos stained with antibodies against GFP (green) and the centriolar marker IFA (magenta); DNA is visualized in blue. Scale bar 10 μm. Insets are fivefold enlargements of boxed regions. (**I**) Centrosomal GFP localization was scored in one-cell stage embryos as shown in panels **F**--**H** as absent, weak focus or strong focus.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.019](10.7554/eLife.07410.019)10.7554/eLife.07410.020Figure 6---figure supplement 1.GFP-SAS-5 and mutants are expressed, and resistant to sas-5 RNAi.Wild type (**A**, **E**, **F**), *gfp::sas-5* (**B**), *gfp::sas-5 L141E* (**C**), and *gfp::sas-5 I247E* (**D**) worms were treated with *sas-5* RNAi (**A**--**D**) or simultaneous *gfp* and *sas-5* RNAi (**E**, **F**), and the resulting embryos imaged by dual DIC and fluorescence time-lapse microscopy. Top panels: one-cell stage embryos, bottom panels: same embryo ∼25 min later. GFP images are maximum intensity projections of 8 z-sections taken at 0.5 μm intervals. Time from the first image is shown in mm:ss. Insets in panels **B**, **C**, **E** and F show 2.5 fold enlargements of boxed regions. (**G**) Quantification of GFP fluorescence intensity in live one-cell stage embryos, shown as a percentage of the average value for wild-type GFP-SAS-5. Rescue of endogenous *sas-5* depletion upon dual RNAi treatment depended on the level of exogenous GFP-SAS-5 expression. Importantly, note that levels of GFP-SAS-5 below those of either of the GFP-SAS-5 mutants, reduced using *gfp* RNAi, were able to rescue the *sas-5* (*RNAi*) phenotype, indicating that the lack of rescue in the latter two strains is not due to insufficient expression levels. To rule out the possibility of *sas-5 (RNAi)* rescue being due to dilution of the *sas-5* RNAi with *gfp* RNAi, embryos expressing GFP-SAS-5 L141E were scored under the same conditions, with all embryos showing the *sas-5 (RNAi)* phenotype (data not shown) Furthermore, GFP-SAS-5 levels at only ∼5% of the levels in the *sas-5 (RNAi)* condition, failed to rescue, further indicating that *sas-5 (RNAi)* is functional under these conditions. (**H**) Western blots of 50 adult worms from each indicated strain probed with antibodies against SAS-5 or GFP, as indicated, and against α-tubulin as loading control. Molecular weight markers are indicated as black dashes. Endogenous SAS-5 exists as two isoforms: the long 404 amino acid isoform and a shorter 288 amino acid isoform, which is likely the result of trans-splicing (Wormbase, F35B12.5c). Note that exogenous *gfp::sas-5* results in the expression of the longer isoform only.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.020](10.7554/eLife.07410.020)Video 1.Time-lapse DIC microscopy of *C. elegans* embryo over the first two cell cycles.Untreated wild type embryo. Frames were captured every 5 s and the movie is played at 12 frames/s. Embryo is oriented with anterior to the left and posterior to the right; elapsed time is shown in minutes and seconds.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.021](10.7554/eLife.07410.021)10.7554/eLife.07410.021Video 2.Time-lapse DIC microscopy of *C. elegans* embryo over the first two cell cycles.Wild type embryo subjected to *sas-5* (*RNAi*). Frames were captured every 5 s and the movie is played at 12 frames/s. Embryo is oriented with anterior to the left and posterior to the right; elapsed time is shown in minutes and seconds.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.022](10.7554/eLife.07410.022)10.7554/eLife.07410.022

We confirmed the expression of the GFP fusion proteins by Western blot analysis and live imaging after *sas-5* RNAi ([Figure 6---figure supplement 1B--D,G](#fig6s1){ref-type="fig"}). Importantly, using time-lapse DIC microscopy to analyze the three transgenic lines generated in this study, we found that expression of GFP-SAS-5 fully rescued the *sas-5(RNAi)* phenotype, allowing all analyzed embryos to progress to the 4-cell stage ([Figure 6C](#fig6){ref-type="fig"} and [Video 3](#video3){ref-type="other"}), as in untreated wild-type embryos. In stark contrast, GFP-SAS-5 mutants that disrupt either the coiled coil (L141E) or the *Implico* oligomerization domain (I247E) were unable to rescue the *sas-5*(*RNAi*) phenotype, such that all embryos underwent monopolar spindle assembly in each blastomere at the second cell cycle and thus failed to result in a 4-cell configuration ([Figure 6D,E](#fig6){ref-type="fig"}, and [Videos 4, 5](#video4 video5){ref-type="other"}). We conclude that both SAS-5 oligomerization interfaces, and hence formation of SAS-5 assemblies larger than merely dimers or trimers, are essential for SAS-5 function in vivo.Video 3.Time-lapse DIC microscopy of *C. elegans* embryo over the first two cell cycles.Embryo expressing GFP-SAS-5 treated with *sas-5* (*RNAi*). Frames were captured every 5 s and the movie is played at 12 frames/s. Embryo is oriented with anterior to the left and posterior to the right; elapsed time is shown in minutes and seconds.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.023](10.7554/eLife.07410.023)10.7554/eLife.07410.023Video 4.Time-lapse DIC microscopy of *C. elegans* embryo over the first two cell cycles.Embryo expressing GFP-SAS-5 L141E treated with*sas-5* (*RNAi*). Frames were captured every 5 s and the movie is played at 12 frames/s. Embryo is oriented with anterior to the left and posterior to the right; elapsed time is shown in minutes and seconds.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.024](10.7554/eLife.07410.024)10.7554/eLife.07410.024Video 5.Time-lapse DIC microscopy of *C. elegans* embryo over the first two cell cycles.Embryo expressing GFP-SAS-5 I247E treated with *sas-5* (*RNAi*). Frames were captured every 5 s and the movie is played at 12 frames/s. Embryo is oriented with anterior to the left and posterior to the right; elapsed time is shown in minutes and seconds.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.025](10.7554/eLife.07410.025)10.7554/eLife.07410.025

We next investigated the distribution of the fusion proteins in one-cell stage embryos treated with *sas-5* (RNAi) by live imaging. Whereas GFP-SAS-5 was observed in foci at centrosomes ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}), foci were not seen for either of the oligomerization mutant versions ([Figure 6---figure supplement 1C,D](#fig6s1){ref-type="fig"}). In order to investigate the localization of the fusion proteins using a more sensitive approach, we analyzed fixed one-cell stage embryos by immunofluorescence with antibodies against GFP and the centriolar marker IFA ([Figure 6F--H](#fig6){ref-type="fig"}). We found that whereas GFP-SAS-5 is enriched at centrioles ([Figure 6F,I](#fig6){ref-type="fig"} and [@bib17]), as was also observed by live imaging, the situation differed for both oligomerization interface mutants. In the case of GFP-SAS-5 L141E, only ∼30% of centrosomes exhibited a clear GFP focus, with the remaining centrosomes exhibiting either no GFP focus, or only a weak focus ([Figure 6G,I](#fig6){ref-type="fig"}). In the case of GFP-SAS-5 I247E, the vast majority of embryos exhibited no detectable GFP focus at centrioles ([Figure 6H,I](#fig6){ref-type="fig"}). We conclude that SAS-5 oligomerization is important for centriole localization, with the *Implico* domain playing a particularly critical role in this respect. Moreover, the presence of GFP-SAS-5 L141E at centrioles in one third of embryos, combined with the fact that this mutant completely failed to rescue the phenotype, raises the possibility that formation of higher-order SAS-5 assemblies is essential for function even if centriolar localization has been achieved.

Discussion {#s3}
==========

*C. elegans* SAS-5 lies at the heart of centriole duplication, given that it associates with SAS-6 ([@bib42]; [@bib60]; [@bib29]; [@bib44]), a critical structural component for the establishment of the ninefold symmetry of centrioles ([@bib39]; [@bib72]; [@bib29]; [@bib73]), and it is required for SAS-6 centriolar localization. Previous biophysical analysis of the SAS-5/SAS-6 interaction was performed using relatively short C-terminal SAS-5 peptides ([@bib60]; [@bib29]), as full-length SAS-5 proved difficult to purify. Our results show that SAS-5 aggregates in vitro due to a ∼20 amino acid segment that may form a β-strand ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} and [Figure 1---figure supplement 4](#fig1s4){ref-type="fig"}); this site is outside the SAS-5 region implicated in SAS-6 binding ([@bib60]; [@bib29]; [@bib44]). Although we cannot exclude the possibility that SAS-5 multimerization through this predicted β-strand is physiologically relevant, we do not favor such interpretation. The aggregates formed by full-length SAS-5, as visualized by EM, are proportional in size to *C. elegans* centrioles even at very low protein concentrations ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). Thus, if present in vivo, the large size of such aggregates would leave little, if any, space for other centriolar components, including SAS-6, SAS-4 and microtubules. Rather, we postulate that in vivo SAS-5 forms a complex with a yet unidentified partner using the ∼20 amino acid segment identified here, and that this complex protects SAS-5 from aggregation in the cell. It is intriguing to speculate whether Protein Phosphatase 2A, which binds SAS-5 in vivo and controls SAS-5 levels ([@bib68]; [@bib38]), may interact with SAS-5 in this region.

Structural and biophysical analysis suggests that SAS-5 can form tight dimers through its *Implico* domain, a novel dimerization interface with no known homologs outside SAS-5 proteins ([Figure 3](#fig3){ref-type="fig"}). These dimers cannot be disrupted even when diluting the protein to concentrations as low as 20 nM ([Figure 4A--D](#fig4){ref-type="fig"}). By comparison, the dimer mediated by the SAS-6 coiled coil is approximately 50-times weaker ([@bib39]), yet the human orthologue HsSAS-6 readily forms dimers in cells ([@bib35]). By extension, it appears reasonable to assume that SAS-5 forms dimers in the cytoplasm of *C. elegans* embryos. Such dimers would associate with SAS-6 ([@bib17]; [@bib60]; [@bib29]; [@bib44]) and possibly SAS-4 ([@bib14a]; [@bib27]), given the moderate interaction strengths of these associations. Our work shows that formation of these tight SAS-5 dimers through the *Implico* domain is necessary for SAS-5 localization to centrioles ([Figure 6H,I](#fig6){ref-type="fig"}). This suggests that the localization mechanism either recognizes the *Implico* domain itself, or depends on a protein association that needs two copies of a distinct SAS-5 epitope, and hence the SAS-5 dimer. Multivalent protein interactions increase the apparent strength (avidity) of association, and are common in biology ([@bib46]). It is possible that the interaction of SAS-5 with SAS-6, known to be necessary for localization of both proteins to centrioles ([@bib17]; [@bib60]; [@bib44]), benefits from such an avidity effect. It will be interesting to determine whether the L141E and I247E SAS-5 mutants prevent SAS-6 recruitment to the nascent centriole assembly site or rather prevent SAS-6 from being organized properly thereafter. In either case, this would likely hinder downstream recruitment of SAS-4, and therefore centriole formation ([@bib15]; [@bib17]; [@bib60]; [@bib44]).

SAS-5 concentrates at centrioles, as illustrated by well-defined GFP foci of this protein ([Figure 6F,I](#fig6){ref-type="fig"}), and we propose that SAS-5 dimers associate further to form higher-order assemblies there. Our SEC-MALS results show that SAS-5 forms tetramers already at 1 μM concentration and a mixture of tetramers and hexamers at 10 μM ([Figure 4B](#fig4){ref-type="fig"}). Although the SAS-5 architecture, with two independent oligomerization interfaces, could theoretically sustain the formation of open-ended protein chains or networks, we believe it is more likely that higher-order SAS-5 assemblies cap at a hexameric size. Such hexamers, formed through the sequential association of three SAS-5 dimers ([Figure 7](#fig7){ref-type="fig"}), should be both kinetically and entropically favored compared to open-ended SAS-5 chains. Hexamer breakdown would require simultaneous disruption of two SAS-5 coiled coils, a rarer event compared to the disruption of a single coiled coil in an open-ended SAS-5 oligomer. Further, in the sequential assembly model of [Figure 7](#fig7){ref-type="fig"}, once the first coiled-coil sequence of a SAS-5 dimer has associated into a folded coiled-coil structure, the degrees of freedom of the second SAS-5 coiled-coil sequence would be reduced, and thus its association into the second folded coiled-coil structure would become entropically favored.10.7554/eLife.07410.026Figure 7.The SAS-5 architecture allows formation of higher oligomers.Schematic representation of SAS-5 oligomerization, showing the coiled-coil and *Implico* domains, without the disordered N- and C-termini of this protein. Tight dimers of SAS-5, mediated by the *Implico* domain, could come together through the coiled coil to form, first, a tetramer and ultimately a hexamer in a concentration-dependent manner. This oligomerisation model does not take into account protein aggregation mediated by the predicted β-strand at the SAS-5 C-terminus.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.026](10.7554/eLife.07410.026)

Disruption of these SAS-5 coiled-coil assemblies by amino acid substitutions (L141E) weakens localization to centrioles ([Figure 6G,I](#fig6){ref-type="fig"}), possibly by impacting the SAS-6 avidity mechanism postulated above. Intriguingly, our data suggest that formation of higher-order SAS-5 assemblies is necessary for function beyond localization, since the GFP-SAS-5 L141E mutant does not rescue centriole duplication upon depletion of endogenous SAS-5, even though it localizes to centrioles in ∼1/3 of embryos ([Figure 6D,G,I](#fig6){ref-type="fig"}). Although some GFP-SAS-5 L141E may be provided from centrioles contributed by the sperm where endogenous SAS-5 is present, we anticipate that any paternal SAS-5 will rapidly exchange with the much larger maternal protein pool ([@bib17]). Thus, we expect that GFP-SAS-5 L141E visualized at centrioles ([Figure 6G,I](#fig6){ref-type="fig"}) is the maternal protein localized there.

The suggestion that higher-order SAS-5 assemblies may be needed for a function other than localization would imply that this protein is not a simple transporter of SAS-6, but that it acts in an additional, more structural, capacity, as has been suggested elsewhere ([@bib60]; [@bib44]). However, FRAP experiments show rapid shuttling of SAS-5 between centrioles and the cytoplasm ([@bib17]), which seemingly conflicts with such a postulated structural role. How can these observations be reconciled?

We speculate that there may exist two different and non-exclusive mechanisms by which large SAS-5 assemblies could assist SAS-6 organization; firstly by providing multivalent SAS-6 attachment sites, and secondly by providing a structural framework. Such SAS-5 assemblies may be transiently located at the site of centriole assembly or, alternatively, could correspond to only a small fraction of total SAS-5, which would have thus gone undetected in FRAP experiments ([@bib17]). SAS-5 assemblies could bind multiple SAS-6 dimers and bring them together in a confined space ([Figure 8](#fig8){ref-type="fig"}). ZYG-1, which interacts with SAS-6 independently of SAS-5 and is also located at the duplication site ([@bib44]), may provide additional enhancement of local SAS-6 concentration. As the interaction affinity for the assembly of SAS-6 oligomers is weak (K~d~ ∼ 100 μM, \[[@bib39]\]) this increase in local SAS-6 concentration may provide a trigger for SAS-6 oligomerisation. Furthermore, if SAS-5 forms defined hexamers as argued above, these hexamers could recruit up to six SAS-6 dimers ([@bib60]; [@bib29]) at the initiation site of SAS-6 oligomerisation. This number of SAS-6 moieties would be sufficient for just over one turn of the proposed SAS-6 spiral ([@bib29]), but not for a SAS-6 ring ([@bib39]; [@bib72]; [@bib73]). Thus, a hexameric SAS-5 architecture would provide an initial structural guide for the configuration of the SAS-6 oligomer. This would be lost in SAS-5 mutants that disrupt its architecture or its interaction with SAS-6 ([@bib17]; [@bib60]; [@bib44]), therefore explaining the absence of centriole formation.10.7554/eLife.07410.027Figure 8.Hypothetical mechanism of SAS-5 function.(**A**) SAS-5 forms tight dimers in the cytoplasm, and it may also associate with SAS-6 dimers depending on the relative levels of each protein. (**B**) SAS-5 localizes at the centriole, where it forms higher-order assemblies. These assemblies bring together multiple SAS-6 dimers in close proximity to one another, thereby increasing the local SAS-6 concentration. Thus, SAS-5 assemblies create a seeding point from which the SAS-6 oligomer forms (**C**); the first step in creating the *C. elegans* central tube.**DOI:** [http://dx.doi.org/10.7554/eLife.07410.027](10.7554/eLife.07410.027)

Our model is conceptually similar to that proposed, albeit in the absence of structural data, for the vertebrate analogue of SAS-5, STIL ([@bib51]), and underlies the possible functional similarities between these two proteins. Although the oligomeric status of STIL has not been resolved yet, that of the *Drosophila* analogue of SAS-5 and STIL, Ana2 ([@bib69]), suggests the presence of higher-order assemblies possibly formed through interactions with the dynein light chain ([@bib74]; [@bib66]). However, the specific structural features of SAS-5 are likely restricted to close homologs of this protein, as we were unable to identify sequences homologous to the SAS-5 coiled-coil and *Implico* domains in either STIL or Ana2. Further, no SAS-5 homolog has been identified in *Trichinella spiralis*, a nematode that may feature SAS-6 cartwheels, rather than spirals, at its centrioles ([@bib29]). Thus, SAS-5 may have evolved in tandem with SAS-6 in order to accommodate the structural divergence of the latter protein and promote spiral formation. Comparison of the SAS-5 structure with those of Ana2 and STIL will be informative in assessing the extent to which the molecular architecture of these proteins is conserved.

In summary, we report here a combined structural and functional analysis of SAS-5 architecture, which underlies the role of large SAS-5 assemblies in centriole duplication in *C. elegans* embryos. We propose that SAS-5 promotes assembly of SAS-6 into oligomers by providing a multivalent structural framework.

Note added in proof {#s3-1}
-------------------

Cottee, Muchalik et al. ([@bib14b]) have now shown that Drosophila Ana2 and vertebrate STIL, the functional equivalents of SAS-5, can also form higher-order oligomers that are essential for function. Both Ana2 and STIL tetramerize through their coiled-coil domains. It remains to be determined whether the different SAS-5 and Ana2/STIL architectures reflect a divergence in centriole architecture between these organisms.

Materials and methods {#s4}
=====================

Construction of protein expression plasmids {#s4-1}
-------------------------------------------

We have constructed a line of entero-bacterial expression vectors, called pFloat, derived from pET30a (Novagen, Madison, WI) and engineered to include N-terminal His~6~- and solubility tags, and a human rhinovirus 3C protease cleavage sequence. To accelerate construct screening we further inserted a ccdB promoter and gene cassette, amplified from pDONR211 (Invitrogen, Grand Island, NY), inside the multi-cloning site. Various solubility tags included thioredoxin (TRX), glutathione S-transferase (GST), S-tag, colicin E9 immunity protein (Im9), maltose-binding protein (MBP), small ubiquiting-like modifier (SUMO), haloalkane dehalogenase (HALO), trigger factor (TF), N utilization substance protein A (NusA), acidic protein MsyB, yellow fluorescent protein (YFP) and enhanced green fluorescent protein (eGFP); the solubility tag sequences were amplified from the pOPIN ([@bib6]) and pGEX (GE Healthcare, Little Chalfont, UK) vector systems, or directly from the *Escherichia coli* strain BL21 genome. All amplifications were performed using high fidelity Phusion polymerase (New England Biolabs, Ipswich, MA), and vectors were constructed using seamless cloning methods (Gibson Assembly, New England Biolabs).

Protein expression and purification {#s4-2}
-----------------------------------

SAS-5 gene fragments from *C. brenneri*, *C. remanei*, *C. sinica* and *C. tropicalis* were synthesised by IDT, Coralville, IA. *C. briggsae* SAS-5 was amplified from genomic DNA (gifted by Marie-Anne Félix, Ecole Normale Supérieure). Full-length or gene fragments encoding for SAS-5 constructs were cloned in pFloat vectors, transformed to *E. coli* strain BL21(DE3) Rosetta2 (Novagen) and grown at 37°C in lysogeny broth (LB) media. Protein expression was induced at OD~600~ 0.6 by [isopropyl-β-D-1-thiogalactopyranoside](http://en.wikipedia.org/wiki/Isopropyl_%CE%B2-D-1-thiogalactopyranoside) (IPTG, 0.5 mM final concentration) and lowering the temperature to 18°C. After ∼16 hr incubation cells were harvested and resuspended in PBS solution (10 mM Na~2~HPO~4~, 1.8 mM KH~2~PO~4~, 137 mM NaCl, 2.7 mM KCl, pH 7.4) supplemented with 350 mM NaCl, 0.1 mM phenylmethanesulfonyl fluoride (PMSF), a protease inhibitor cocktail (cOmplete, Roche, Basel, Switzerland), 0.25 mg/ml lysozyme and 10 μg/ml DNAse I. Resuspended cells were disrupted by sonication while chilled on ice, and cell lysate was cleared by centrifugation at 40,000×*g* and 0.22 μM filtration. Imidazole at 20 mM final concentration was added to clarified lysates prior to incubation with TALON (GE Healthcare) metal affinity resin pre-equilibrated with PBS supplemented with 350 mM NaCl and 20 mM imidazole. Resin beads were washed with PBS supplemented with 350 mM NaCl, 1 mM β-mercaptoethanol and 20 mM imidazole, and protein was eluted in PBS supplemented with 350 mM NaCl, 1 mM β-mercaptoethanol and 500 mM imidazole.

Further purification of proteins was performed at 4°C by anion- (HiTrap Q HP, GE Healthcare) or cation-exchange (HiTrap SP HP, GE Healthcare) chromatography in 10 mM Tris--HCl or Na~2~HPO~4~, 50 mM NaCl, 3 mM β-mercaptoethanol, pH 8.0 (for anion-exchange) or pH 6.5 (for cation-exchange) running buffer, and proteins were eluted using a NaCl gradient to 2 M. His~6~- and solubility-tags were cleaved, whenever necessary, by overnight incubation with Prescission protease (GE Healthcare); proteins were further purified by size-exclusion chromatography in HiLoad Superdex 75, Superdex 200 or Superose 6 columns (GE Healthcare) equilibrated in 10 mM Tris--HCl, 300 mM NaCl, 2 mM β-mercaptoethanol, pH 7.5 buffer. Pure protein fractions were buffer-exchanged by dialysis, and concentrated by centrifugal ultrafiltration. Protein concentration was estimated by UV absorption at 280 nm, and protein identity confirmed by electrospray ionization mass-spectrometry.

Biophysical analysis {#s4-3}
--------------------

Far-UV CD spectra (260--180 nm) were measured using a Jasco (Easton, MD) J-815 Spectropolarimeter at 10°C. Protein samples were exchanged to a 10 mM NaH~2~PO~4~, 100 mM NaF, 1 mM β-mercaptoethanol, pH 7.5 buffer. CD sample concentrations are shown in [Table 3](#tbl3){ref-type="table"}. Data were truncated at high tension voltage exceeding 800 V. After buffer background subtraction, data were smoothed using a Savitzky--Golay filter ([@bib62]). CD spectra were deconvoluted using the DICHROWEB server ([@bib75]). Measurements of thermal stability monitored CD signal at 222 nm while temperature was increased by 1°C/min between 4°C and 90°C.10.7554/eLife.07410.028Table 3.CD and SEC-MALS experimental details**DOI:** [http://dx.doi.org/10.7554/eLife.07410.028](10.7554/eLife.07410.028)CDProtein nameConcentration (μM)SAS-5~FL~1.5SAS-5~Δ282--295~3SAS-5~FLEX~3SAS-5~2--265~6SAS-5~2--265~ L141E6SAS-5~2--265~ L141E/M167E6SAS-5~--265~ I247E6SAS-5~2--265~ L141E/I247E6SAS-5~125--265~10SAS-5~CC~20SAS-5~CC~ L141E20SAS-5~Imp~20SAS-5~Imp~ I247E20SAS-5 N-terminus20SAS-5 C-terminus5SEC-MALSProtein nameMonomeric MW (kDa)Size exclusion columnMinimum concentration (μM)[\*](#tblfn10){ref-type="table-fn"}Maximum concentration (μM)[\*](#tblfn10){ref-type="table-fn"}SAS-5~FL~46Superose60.100.57SAS-5~FLEX~-MsyB62Superose60.039.5SAS-5~2--265~-MsyB ([Figure 4](#fig4){ref-type="fig"})46Superose60.0241SAS-5~2--265~-MsyB ([Figure 5](#fig5){ref-type="fig"})46Superdex2000.0541SAS-5~2--265~ L141E46Superdex2001.3263SAS-5~2--265~ L141E/M167E46Superdex2001.1663SAS-5~2--265~ I247E46Superdex2000.0563SAS-5~2--265~ L141E/I247E46Superdex2000.8263SAS-5~Imp~6.5Superdex752.9292SAS-5~CC-L~12.5Superdex750.18152*C. briggsae* SAS-5 (96--199)12.7Superdex750.10149*C. brenneri* SAS-5 (1--82)10.2Superdex750.21186*C. remanei* SAS-5 (98--206)13Superdex750.21146*C. sinica* SAS-5 (94--204)13Superdex750.16145*C. tropicalis* SAS-5 (94--199)12.5Superdex750.12152[^10]

SEC-MALS analysis was performed at 20°C using analytical Superdex 75, Superdex 200 or Superose 6 columns (GE Healthcare) and a Shimadzu (Kyoto, Japan) chromatography system, connected in-line to a Heleos8+ multi-angle light scattering detector and an Optilab T-rEX refractive index (RI) detector (Wyatt Technologies, Goleta, CA). A 1:1 dilution series of protein samples in 10 mM Tris--HCl, 300 mM NaCl, 2 mM β-mercaptoethanol, pH 7.5 buffer were injected in this system, and the resulting MALS, RI and UV traces processed in ASTRA 6 (Wyatt Technologies). On-column protein concentration was calculated from the differential RI, assuming dn/dc of 0.1850 ml/g. SEC-MALS data were fit with a two-state model to derive association parameters, and the resulting K~d~ estimated from the inflection point of the fit. Details of SEC-MALS sample concentrations, monomeric molecular weight and column used are shown in [Table 3](#tbl3){ref-type="table"}.

Native mass-spectrometry was performed on protein samples in 250 mM NH~4~Acetate, pH 7.5 buffer using a modified Synapt G1 High Definition Mass Spectrometry Quadrupole Time of Flight instrument (Waters, Milford, MA) ([@bib9]) calibrated using 10 mg/ml CsI. 2 μl aliquots of sample were delivered by nano-electrospray ionization via gold-coated capillaries, prepared in house ([@bib28]). Instrumental parameters were as follows: source pressure 6.0 mbar, capillary voltage 1.20 kV, cone voltage 50 V, trap energy 10 V, bias voltage 5 V and trap pressure 0.0163 mbar.

For negative stain electron microscopy SAS-5~FL~ protein samples (5 μl, 0.1 mg/ml) in 10 mM Tris--HCl, 300 mM NaCl, 2 mM β-mercaptoethanol, pH 7.5 buffer were applied to glow-discharged homemade carbon-coated copper mesh grids and allowed to adsorb for 1 min. After blotting off any excess liquid, negative stain was applied by adding 3 μl of 1% wt/vol uranyl acetate to the grid. Blotting and staining was repeated 2 times, and the grids were then allowed to air dry for 10 min. The grids were imaged in a JEOL (Tokyo, Japan) JEM-2010 electron microscope equipped with a high brightness LaB~6~ filament and an ORIUS SC1000 (Model 832) camera (Gatan, Abingdon, UK). Images were acquired using an accelerating voltage of 200 kV, at a nominal magnification of 16,000× to 52,000×.

Crystallization, crystallographic data collection and refinement {#s4-4}
----------------------------------------------------------------

Crystals were obtained using the sitting drop vapor diffusion technique. A Mosquito robot (TTP LabTech, Melbourn, UK) was used to setup 200 nL-size drops with 1:1 and 1.3:0.7 ratios of protein to mother liquor. For SAS-5~CC~, protein in 10 mM Tris--HCl pH 7.5, 200 mM NaCl buffer and at concentration of 20 mg/ml was mixed with 0.1 M MOPS/HEPES-Na pH 7.5, 12.5% wt/vol PEG 1000, 12.5% wt/vol PEG 3350, 12.5% wt/vol MPD, 0.03 M NaNO~3~, 0.03 M Na~2~HPO~4~, 0.03 M (NH~4~)~2~SO~4~. Crystals developed at 4°C in 30 days, were flash-cooled in liquid nitrogen and diffracted to a maximum resolution of 1.73 Å at the Diamond Light Source (DLS, Harwell, UK) beamline I04. The space group was determined as P2~1~2~1~2~1~ with eight molecules per asymmetric unit. Crystallographic data (statistics in [Table 1](#tbl1){ref-type="table"}) were integrated in MOSFLM ([@bib43]) or XDS ([@bib34]) and scaled by Aimless ([@bib21]) or XSCALE ([@bib34]). Scaling reveals substantial diffraction anisotropy, which was corrected using the Diffraction Anisotropy Server (UCLA Molecular Biology Institute, [@bib70]) whilst applying a high resolution cutoff of 1.8 Å. Statistics of the anisotropically corrected data are shown in [Table 2](#tbl2){ref-type="table"}. Phase information for SAS-5~CC~ was obtained from a highly redundant dataset with maximum resolution of 1.9 Å collected on Pb-derivatized crystals at a wavelength of 0.947 Å at the DLS beamline I03. For Pb-derivatization the native SAS-5~CC~ crystals were incubated with 1 mM trimethyl lead (IV) acetate for 16 hr prior to cooling. Phasing by SAD was performed using PHENIX.autosol ([@bib1]) which located and refined 9 Pb sites to produce a density map with initial figure of merit of 0.36. Initial model building was done with PHENIX.autobuild (291 residues built, 222 identified out of 427 residues in the asymmetric unit). Iterative model building with COOT ([@bib20]) and refinement against the anisotropically corrected native data in Buster 2.10 ([@bib8]) using automatic NCS and TLS restraints ([@bib67]) yielded the final SAS-5~CC~ model.

For SAS-5~Imp~, protein in 10 mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT buffer and at concentration of 10 mg/ml was mixed with 0.1 M MES/imidazole pH 6.4, 10% wt/vol PEG 20,000, 20% vol/vol PEG MME 550, 0.1 M carboxylic acids mixture ([@bib26]). Crystals developed at 18°C in 3 days, were cryo-protected by brief immersion to mother liquor supplemented with 20% vol/vol glycerol, flash-cooled in liquid nitrogen and diffracted to 1.0 Å at the European Synchrotron Radiation Facility (ESRF, Grenoble, France) beamline ID14-4. The space group was determined as P12~1~1 with two molecules per asymmetric unit. Data integration and scaling was performed as in SAS-5~CC~ ([Table 1](#tbl1){ref-type="table"}), however no anisotropy correction was required. Phase information was obtained from a highly redundant dataset with maximum resolution of 1.7 Å collected on Hg-derivatized crystals at a wavelength of 1.007 Å at the DLS beamline I02. For Hg-derivatization native SAS-5~Imp~ crystals were incubated with 2 mM mercury (II) acetate for 16 hr prior to cooling. Phasing by SAD was performed using PHENIX.autosol ([@bib1]) which located and refined 2 Hg sites to produce a density map with initial figure of merit of 0.39. Initial model building was done with PHENIX.autosol (86 residues built and 51 identified out of 116 residues in the asymmetric unit). Iterative model building with COOT ([@bib20]) and refinement against the native data in PHENIX.refine ([@bib1]) using explicit hydrogens and atom-level anisotropic restraints.

Model quality was assessed by MolProbity ([@bib13]). For graphical representation, we used UCSF Chimera ([@bib57]). Initial crystal inspection and data collection took place at the DLS beamline I04-1.

MD simulations {#s4-5}
--------------

All MD simulations were performed using GROMACS 4 ([@bib59]) and the GROMOS96 53a6 force field ([@bib52]). The crystal structure of SAS5~CC~ was placed in a cubic simulation box of 1452 nm^3^ volume with periodic boundary conditions. The protein was solvated by adding 10,637 explicit SPC water molecules. Na^+^ and Cl^−^ ions were added to the final concentration of 0.1 M. The system was first minimized with the steepest descend algorithm, equilibrated in constant temperature (NVT, 300 K) for 100 ps, and followed by equilibration in constant temperature and pressure (NPT, 1 bar) for 500 ps. The pressure was controlled with an isotropic Parrinello-Rahman barostat ([@bib53]) applied to the entire system with a time constant of 2.0 ps and compressibility of 4.5 × 10^−5^ bar^−1^. The temperature was controlled with two velocity rescaling thermostats ([@bib5]) applied to the protein and solvent, with a time constant of 0.1 ps. Electrostatic interactions were calculated using the particle-mesh Ewald ([@bib16]) summation method. Ten replicate simulations of 45 ns duration were performed in the Oxford Advanced Research Computing facility.

Nematode strains and RNA interference {#s4-6}
-------------------------------------

The genomic sequence of *sas-5* (Wormbase, F35B12.5a) was recoded for resistance to RNAi directed against the endogenous gene, and synthesized by Genscript (Piscataway, NJ). Intronic sequences were kept intact, as well as the bases neighboring the splice sites: 3 bases at 3′ ends and 6 bases at 5′ ends of exons. The codon adaptation index was preserved at the level of the wild type (WT: 0.777, recoded: 0.712). The recoded gene was amplified and cloned in pIC26 using the SpeI restriction site. pIC26 contains a *pie-1* promoter and 3′UTR, as well as a GFP coding sequence fused upstream of and in frame with *sas-5* ([@bib12]). *C. elegans* culture was performed according to standard procedures ([@bib7]). GFP--SAS-5 transgenic animals were generated by bombardment ([@bib58]). Integrated lines were recovered after bombardment with *gfp::sas-5 L141E* (strain GZ1301; isIs51*{pie-1::gfp::sas-5\[recL141E\]}*) and *I247E* (strain GZ1302; isIs52*{pie-1::gfp::sas-5\[recI247E\]}*), but GFP-SAS-5 bombardment led to the recovery of non-integrated lines. For these experiments a line with \<50% transmission of the extra chromosomal array was used (strain GZ1300; isEx5*{pie-1::gfp::sas-5\[rec\]}*). RNAi was carried out by selecting L3--L4 wild-type hermaphrodites and feeding them for 26 hr at 24°C using the *sas-5*(*RNAi*) feeding strain, which targets nucleotides 301--1170 of the genomic sequence ([@bib17]).

Antibodies and immunofluorescence {#s4-7}
---------------------------------

Embryos were prepared for immunofluorescence essentially as described ([@bib24]), with a fixation time of 2 min in −20°C methanol and an additional blocking step in PBS, 2% wt/vol BSA before antibody incubation. Primary and secondary antibodies were diluted in PBS as follows: rabbit anti-GFP (gift from Viesturs Simanis, EPFL, 1/500), mouse anti-IFA ([@bib45], 1/50), goat anti-GFP (Abcam, Cambridge, UK, ab6673, 1/250), goat anti-rabbit Alexa Fluor 488, goat anti-mouse Alexa Fluor 568, donkey anti-goat Alexa Fluor 488, donkey anti-mouse Alexa Fluor 568 (Life Technologies, Grand Island, NY, all 1/500). Primary antibodies were incubated overnight at 4°C and secondary incubations were at room temperature for 1 hr. 1 μg/ml Hoechst 33,258 (Sigma-Aldrich, St. Louis, MO) was used to visualize DNA.

Microscopy {#s4-8}
----------

Time-lapse DIC microscopy of early embryos was carried out as described ([@bib24]), recording one image every 5 s at 24°C. A Zeiss (Oberkochen, Germany) LSM 700 confocal microscope was used for fluorescence microscopy. Z-sections were imaged at an interval of ∼0.3 μm. Fluorescent images in [Figure 6F--H](#fig6){ref-type="fig"} are maximum intensity projections. Dual time-lapse and fluorescence DIC imaging was performed on a Zeiss Axioplan 2 ([@bib4]). The motorised filter wheel, two external shutters, and the 1392 × 1040 pixel, 12-bit Photometrics CoolSNAP ES2 (Photometrics, Tucson, AZ) were controlled by μManager ([@bib19]). Images were acquired with an exposure time of 100 ms for the DIC and 200 ms for the GFP channel using the Zeiss Filter Set 10 (GFP). The GFP images presented in [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} are maximum intensity projections of 8 z-sections acquired with an interval of 0.5 μm. For quantification of fluorescence intensities, the integrated intensity was measured from three areas of fixed size within each embryo and then averaged. The average background fluorescence of wild-type (GFP-negative) embryos was subtracted, then values were normalized to the average value of the GFP-SAS-5 wild type intensity. All images were processed and fluorescence intensities measured using ImageJ ([@bib64]).

Western blotting {#s4-9}
----------------

Embryos were synchronized by bleaching adult worms, hatched and matured at 24°C; 50 adult worms were then collected manually, boiled in Laemmli buffer for 5 min, sonicated, and loaded on a 4--12% wt/vol SDS-PAGE (Biorad, Hercules, CA). Proteins were transferred to a 0.45 μm nitrocellulose membrane, blocked with 5% wt/vol milk powder in PBS, 0.1% vol/vol Tween-20, and blotted with rabbit anti-SAS-5 (full length, 1/1000, ([@bib17])) or rabbit anti-GFP (1/1000, gift from Viesturs Simanis, EPFL), then re-blotted with mouse anti-α-tubulin (1/10,000, DM1α, Sigma-Aldrich) antibodies. Immunocomplexes were visualized using anti-rabbit or anti-mouse HRP conjugated secondary antibodies at 1/5000 dilution (Promega, Madison, WI), chemiluminescence kit (Roche), and X-ray films (Fujifilm, Tokyo, Japan).

Sequence notes {#s4-10}
--------------

SAS-5 protein sequences in this study correspond to UniProt database entries Q20010 (*C. elegans*), Q60M48 (*C. briggsae*), G0NH40 (*C. brenneri*) and E3LPN2 (*C. remanei*). *C. sinica* and *C. tropicalis* SAS-5 sequences were identified from the respective genomes by blast searches starting from the *C. elegans* variant. For *C. sinica* the University of Edinburgh sp. 5 genome project (Csp5_scaffold_00353) was used, while for *C. tropicalis* the Genome Institute at Washington University *Caenorhabditis* sp. 11 genome project (Csp11.Scaffold629) served as reference. The flexible linker used in SAS-5~FLEX~ to replace the 'sticky' amino acid segment has the sequence SGAAGSSGAAGSSG.
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Major datasets {#s6-1}
--------------

The following datasets were generated:

Rogala KB, Hatzopoulos GN, Vakonakis I, 2015,Structure of the C. elegans SAS-5 coiled coil domain,<http://www.rcsb.org/pdb/explore/explore.do?structureId=4YV4>,Publicly available at RCSB Protein Data Bank (Accession No: 4YV4).

Rogala KB, Hatzopoulos GN, Vakonakis I, 2015,Structure of the C. elegans SAS-5 Implico dimerization domain,<http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YNH>,Publicly available at RCSB Protein Data Bank (Accession No: 4YNH).

Standard used to collect data: Crystallographic data and structure refinement statistics have been reported according to usual (but not standardized) format. Structures have been validated by the databank and the validation documents are attached.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your work entitled "The *Caenorhabditis elegans* protein SAS-5 forms large oligomeric assemblies critical for centriole formation" for peer review at *eLife*. Your submission has been favorably evaluated by John Kuriyan (Senior editor) and two reviewers, one of whom is a member of our Board of Reviewing Editors.

In this manuscript, Rogala et al., investigate the structural characteristics of SAS-5, a *C. elegans* protein that is essential for centriole formation. Using a variety of biochemical techniques, the authors show that SAS-5 oligomerizes via multiple domains and that SAS-5 oligomerization essential for proper centriole duplication in the *C. elegans* embryo. Furthermore, the authors determined the crystal structures of a central coiled-coil domain and a novel dimerization domain, which the authors term Implico. This study is well done and provides novel insight on the structure and function of a key centriole protein. Furthermore, the identification of a novel dimerization domain will no doubt be of considerable interest to the wider community.

We have a number of questions that we would like you to address, by further discussion in the text.

How could the flexible SAS-5 hexamer that you propose facilitate the formation of a defined SAS-6 spiral and why would oligomerisation stop with a hexamer at all? Further oligomerization could easily be explained if one considers all the other alternative arrangements of the oligomers e.g., the two coiled coil parts (from one Implico domain dimer) joining up to form a parallel dimer with a free valency to take up a third coiled coil helix (linker between Implico domain and coiled coil is long enough for that) or coiled coil helices provided by different SAS-5 dimers coming together from different sides such that one would get chains or meshworks. How do you think that the resulting amorphous and flexible assembly structurally facilitates a defined SAS-6 assembly.

You propose that SAS-5 multimerization is critical for organizing SAS-6 complexes into spirals with 9-fold symmetry (see the last sentence of the Abstract, the last sentence of the Introduction, and the Discussion). Since this hypothesis has not been tested, I feel that this statement is inappropriate for the Abstract and Introduction. More work could be done to see if purified SAS-5 affects SAS-6 assembly in vitro, but I think that is beyond the scope of this paper. However, I think speculation is appropriate for the Discussion section. Furthermore, in the Discussion section the authors should also consider the possibility that the predicted Beta sheet spanning a.a. 282--295 in SAS-5 might be physiologically relevant and promote further multimerization beyond hexamers. The authors cannot dismiss this possibility since they never tested the functionality of SAS-5~Δ282-295~ in vivo.

The model in [Figure 8](#fig8){ref-type="fig"} is misleading since the authors never tested if SAS-5 oligomerization affects SAS-6 organization. This figure should be removed.

No reference is made to an earlier characterization of SAS-5 structure published by [@bib65] (Worm). The authors should mention this earlier work, why their results are different, and remove the lines in the Discussion section that claim that their study is the first structural and functional analysis of SAS-5 architecture.

The MALS experiments with the coiled coil construct have not been done at higher concentrations, the use of MD analysis to demonstrate trimerisation of the coiled coil is rather weak evidence and some of the MALS runs in [Figure 2G](#fig2){ref-type="fig"} are a bit puzzling: The broad black curve gives a flat MW throughout the peak and the tail, while the brown curves that elute at that tail position are less than half that MW. If the assembly goes concentration dependent monomer-dimer-trimer then that behaviour is a bit hard to understand as the black curve should reflect these steps throughout its very broad peak.

It is not always 100% clear whether the solubility tag has been removed or left on.

CD deconvolution into secondary structure percentages tends not to be very accurate in terms of exact numbers and I would consider just mentioning that constructs where found to be mainly helical and so on.

I\'m surprised that the authors didn\'t test if SAS-5 multimerization affects SAS-6 recruitment in vivo. The strong centriole/cell division phenotype seen in the L141E and I247E mutants might be due to the fact that not enough SAS-6 is recruited to the nascent daughter centriole, rather than SAS-6 not being organized properly once delivered there. The authors could use immunofluorescence to test this possibility.

The model in [Figure 4](#fig4){ref-type="fig"} should be revised so that it is clear that the proposed model is for a modified version of SAS-5 that lacks the central predicted Beta sheet (SAS-5~FLEX~).
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Author response

*How could the flexible SAS-5 hexamer that you propose facilitate the formation of a defined SAS-6 spiral and why would oligomerisation stop with a hexamer at all? Further oligomerization could easily be explained if one considers all the other alternative arrangements of the oligomers e.g., the two coiled coil parts (from one Implico domain dimer) joining up to form a parallel dimer with a free valency to take up a third coiled coil helix (linker between Implico domain and coiled coil is long enough for that) or coiled coil helices provided by different SAS-5 dimers coming together from different sides such that one would get chains or meshworks. How do you think that the resulting amorphous and flexible assembly structurally facilitates a defined SAS-6 assembly*.

We accept that our SEC-MALS results do not conclusively show that SAS-5 oligomers are limited to hexamers as opposed to open-ended chains or networks. Unfortunately, our attempts at probing the limits of SAS-5 oligomers using AUC and SAXS have not met with success due to protein precipitation and aggregation during these experiments. Formation of defined SAS-5 hexamers is thus a conjecture, and as such we have moved their mention from the Results section to the Discussion of the revised manuscript. There, we acknowledge that SAS-5 open-ended polymers are possible, but argue that SAS-5 hexamers would be kinetically and entropically more stable, compared to open-ended polymers. For the same reasons [Figure 4](#fig4){ref-type="fig"} of the original manuscript has been re-positioned as [Figure 7](#fig7){ref-type="fig"} of the Discussion.

SAS-5 oligomerisation would assist SAS-6 self-assembly through two different mechanisms. Firstly and primarily, SAS-5 oligomers could bind multiple SAS-6 dimers, bringing them close together in space and thereby increasing the SAS-6 local concentration. This type of avidity effect is very likely necessary for SAS-6 oligomerisation, as the self-assembly interaction strength of this protein is weak (K~d~ ∼100 μM, see Kitagawa et al. Cell, 2011). In addition to the mechanism above, if SAS-5 oligomers do not readily exceed the tetrameric/hexameric states seen in solution, this would imply a close approach of up to four or six SAS-6 dimers per SAS-5 oligomer. This number of SAS-6 moieties would be sufficient for a turn of the SAS-6 spiral to form (4.5 SAS-6 dimers/turn), but not for a complete SAS-6 ring (9 SAS-6 dimers/ring). In the revised discussion we present this line of thought more clearly, but also stress that it is simply a hypothesis.

*You propose that SAS-5 multimerization is critical for organizing SAS-6 complexes into spirals with 9-fold symmetry (see the last sentence of the Abstract, the last sentence of the Introduction, and the Discussion). Since this hypothesis has not been tested, I feel that this statement is inappropriate for the Abstract and Introduction. More work could be done to see if purified SAS-5 affects SAS-6 assembly* in vitro*, but I think that is beyond the scope of this paper. However, I think speculation is appropriate for the Discussion section. Furthermore, in the Discussion section the authors should also consider the possibility that the predicted Beta sheet spanning a.a. 282--295 in SAS-5 might be physiologically relevant and promote further multimerization beyond hexamers. The authors cannot dismiss this possibility since they never tested the functionality of SAS-5*~*Δ282-295*~ in vivo.

We have removed references to SAS-5 assisting SAS-6 organisation into spirals with 9-fold symmetry from the Abstract, and make it clear at the end of the Introduction that the SAS-5 oligomerisation driving SAS-6 self-assembly is merely a hypothesis, which is now expanded on only in the Discussion section. Also in the Discussion, we now acknowledge that SAS-5 polymerisation through the predicted beta-strand may be physiologically relevant, although we do not expect this to be the case as the aggregates of SAS-5 tend to be as big as centrioles. Should these SAS-5 aggregates occur in vivo, they would leave little space for SAS-6, SAS-4 and microtubules.

*The model in* [*Figure 8*](#fig8){ref-type="fig"} *is misleading since the authors never tested if SAS-5 oligomerization affects SAS-6 organization. This figure should be removed*.

The reviewers are correct that our work does not directly test the effect of SAS-5 on SAS-6 organisation. However, we believe that [Figure 8](#fig8){ref-type="fig"} is valuable as it presents a hypothesis (or working model) for SAS-5 function that is consistent with existing results. Our work clearly shows that SAS-5 oligomerises and that this oligomerisation is necessary for function. Further, it has long been known (e.g. [@bib42]) that SAS-5 function is needed for SAS-6 self-assembly in *C. elegans* centrioles. [Figure 8](#fig8){ref-type="fig"} brings these two ideas together in a schematic form.

We believe that models of this type make manuscripts approachable to a wider audience, thus we have decided to retain [Figure 8](#fig8){ref-type="fig"} in the revised manuscript. Nevertheless, we have modified the Discussion and [Figure 8](#fig8){ref-type="fig"} legend to make clear that this model is simply a hypothesis. However, should you (similar to the reviewers) feel strongly about removing [Figure 8](#fig8){ref-type="fig"}, we would be prepared to move it into a supplementary panel related to the new [Figure 7](#fig7){ref-type="fig"}.

*No reference is made to an earlier characterization of SAS-5 structure published by* [@bib65] *(Worm). The authors should mention this earlier work, why their results are different, and remove the lines in the Discussion section that claim that their study is the first structural and functional analysis of SAS-5 architecture*.

Shimanovskaya et al. suggested that SAS-5 forms tetramers in solution based on SEC-MALS and SAXS data, and that the SAS-5 N-terminal region ahead of the coiled coil of this protein is unstructured. However, the authors of this study did not provide a structural basis for SAS-5 oligomerisation, nor did they provide a combined SAS-5 structure-function relationship. We now reference this work in appropriate sections of our revised manuscript (in the Results), and we removed the statement of priority. Comparison of the SAS-5 oligomeric state suggested in Shimanovskaya et al. with our work is, however, difficult. The authors of the earlier paper only show SEC-MALS data from single, unspecified, concentrations of their different SAS-5 constructs. The raw SAXS data are not shown, nor is there an analysis of SAXS data as a function of SAS-5 concentration.

*The MALS experiments with the coiled coil construct have not been done at higher concentrations, the use of MD analysis to demonstrate trimerisation of the coiled coil is rather weak evidence and some of the MALS runs in* [*Figure 2*G](#fig2){ref-type="fig"} *are a bit puzzling: The broad black curve gives a flat MW throughout the peak and the tail, while the brown curves that elute at that tail position are less than half that MW. If the assembly goes concentration dependent monomer-dimer-trimer then that behaviour is a bit hard to understand as the black curve should reflect these steps throughout its very broad peak*.

We are puzzled by these comments. SEC-MALS experiments of SAS-5 coiled coils (for all nematode species) have been done up to on-column concentrations of ∼150 μM or more (see [Figure 2](#fig2){ref-type="fig"}, [Figure 2--figure supplement 2](#fig2s2){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}), which required the injection of protein samples with concentration in excess of 4 mM. In both [Figure 2](#fig2){ref-type="fig"} and [Figure 2--figure supplement 2](#fig2s2){ref-type="fig"}, the SAS-5 coiled coils can be clearly seen to be capped at the trimer size over the last two / three data series (typically from an on-column concentration of 60 μM and higher). We believe this is a strong argument for the trimeric nature of this coiled coil; the MD analysis was performed to "undo" the crystal packing distortions of the coiled coil, rather than to prove its trimerisation. Finally, the broad black peaks of [Figure 2G](#fig2){ref-type="fig"} (and similar ones in [Figure 2--figure supplement 2](#fig2s2){ref-type="fig"}) are the result of overloading the size exclusion column with protein in our last one or two data series. In these cases the broadness of the SEC-MALS peak does not represent protein equilibria, as the reviewers suggest, but simply a protein overload. For example, the protein on-column concentration over the flat MW section of the broad peak in [Figure 2G](#fig2){ref-type="fig"} is always in excess of 30 μM, as calculated from the differential refractive index. We have added a note in figure legends to explain the origin of these broad peaks as protein overloads.

*It is not always 100% clear whether the solubility tag has been removed or left on*.

We have modified the text and figure legends to explicitly state when the solubility tag was present in the proteins utilised.

*CD deconvolution into secondary structure percentages tends not to be very accurate in terms of exact numbers and I would consider just mentioning that constructs where found to be mainly helical and so on*.

The reviewers are correct to suggest that CD deconvolution is not accurate enough to provide absolute percentage terms of secondary structure, which is why in the text we never refer to the constructs in terms other than "mainly helical" etc. However, we were very careful in doing all CD measurements and data analysis under closely matched conditions, which is why we believe that the relative secondary structure changes seen in CD deconvolution analysis have merit. This is especially valuable when comparing wild-type and mutant proteins, as in [Figure 5--figure supplement 1](#fig5s1){ref-type="fig"}, where CD deconvolution can assist readers with less expertise in interpreting the raw CD data. Thus, we would prefer not to remove the CD deconvolution bars from the figures, but we rather explicitly state in figure legends that this type of analysis is semi-quantitative.

*I\'m surprised that the authors didn\'t test if SAS-5 multimerization affects SAS-6 recruitment* in vivo*. The strong centriole/cell division phenotype seen in the L141E and I247E mutants might be due to the fact that not enough SAS-6 is recruited to the nascent daughter centriole, rather than SAS-6 not being organized properly once delivered there. The authors could use immunofluorescence to test this possibility*.

This is an interesting suggestion. Unfortunately, however, an immunofluorescence experiment using antibodies directed against SAS-6 cannot ascertain whether or not SAS-6 is recruited in the L141E and I247E mutant conditions. Indeed, SAS-6 at centrioles inherited from sperm is extremely stable, as recently reported (PMID 25906994). Moreover, due to the minute size of centrioles in *C. elegans*, the nascent centriole in one-cell stage embryos cannot be resolved by confocal microscopy from the paternally contributed centrioles. Thus, two SAS-6 foci are observed in both wild type and *sas-5(RNAi)* one-cell stage embryos. Therefore, discriminating between a scenario in which the protein is not recruited at all from one in which it is recruited initially but not organized properly thereafter in the mutant conditions is not possible by this means. An alternative that could be envisaged would be to use a transgenic line expressing a detectable fusion protein between SAS-6 and a fluorescent protein other than GFP (e.g. mCherry-SAS-6), but this is not available. In the absence of such experiments, we now indicate the possibility mentioned by the reviewers in the revised manuscript (paragraph two, Discussion section).

*The model in* [*Figure 4*](#fig4){ref-type="fig"} *should be revised so that it is clear that the proposed model is for a modified version of SAS-5 that lacks the central predicted Beta sheet (SAS-5*~*FLEX*~*)*.

The former [Figure 4](#fig4){ref-type="fig"} (now [Figure 7](#fig7){ref-type="fig"}) does not include the section where the predicted beta-strand would locate, but only the structured coiled coil and Implico segments. We now make it explicit in the figure legend that this oligomerisation model is valid for SAS-5 in the absence of the predicted beta-strand.

[^1]: Anisotropic diffraction of 2.17 Å, 2.59 Å and 1.73 Å highest resolution along the a^\*^, b^\*^ and c^\*^ axes, respectively, based on a mean I/σ(I) \> 2.0 criterion.

[^2]: Anisotropic diffraction of 2.18 Å, 3.03 Å and 2.17 Å highest resolution along the a^\*^, b^\*^ and c^\*^ axes, respectively, based on a mean I/σ(I) \> 2.0 criterion.

[^3]: By Aimless ([@bib21]), values in parentheses correspond to the high resolution shell.

[^4]: 98.0% complete to 2.26 Å.

[^5]: 98.8% complete to 2.03 Å.

[^6]: From PHASER ([@bib47]).

[^7]: From RESOLVE ([@bib71]).

[^8]: From MolProbity ([@bib13]).

[^9]: Derived from the UCLA Diffraction Anisotropy Server ([@bib70]).

[^10]: Refers to on-column concentration calculated from the protein differential refractive index.
